Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDAH1 | O94760 | 1/20 | 0.59 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 5/20 | 0.52 |
| ▸ | NPC1 | O15118 | 4/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.51 |
| ▸ | TSHR | P16473 | 3/20 | 0.51 |
| ▸ | HPGD | P15428 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | GFER | P55789 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18776132 | 0.88 | DDAH1 (0.53) | DDAH1ADRA2CALDH1A1PSMB8RAB9A | |
| SCHEMBL18758063 | 0.88 | DDAH1 (0.57) | DDAH1ADRA2CALDH1A1PSMB8RAB9A | |
| SCHEMBL28366757 | 0.86 | DDAH1 (0.59) | DDAH1ADRA2CALDH1A1PSMB8RAB9A | |
| SCHEMBL11824208 | 0.86 | DDAH1 (0.60) | DDAH1ADRA2CALDH1A1PSMB8RAB9A | |
| SCHEMBL28808840 | 0.85 | SMN1; SMN2 (0.54) | DDAH1ADRA2CALDH1A1PSMB8RAB9A | |
| SCHEMBL29751881 | 0.85 | SMN1; SMN2 (0.54) | DDAH1ADRA2CALDH1A1PSMB8RAB9A | |
| SCHEMBL16237419 | 0.84 | DDAH1 (0.62) | DDAH1ADRA2CALDH1A1PSMB8RAB9A | |
| SCHEMBL29751870 | 0.84 | DDAH1 (0.50) | DDAH1ADRA2CALDH1A1PSMB8RAB9A | |
| SCHEMBL12755466 | 0.84 | RAB9A (0.52) | DDAH1ADRA2CALDH1A1RAB9ANPC1 | |
| SCHEMBL28808034 | 0.84 | DDAH1 (0.50) | DDAH1ADRA2CALDH1A1PSMB8RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 221 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9119307-B2 | Housing for a portable electronic device | TICONA LLC (US) | 2015-08-25 | — | — | US | claimed |
| WO-2015122942-A1 | MOLDED PART FOR USE IN A PORTABLE ELECTRONIC DEVICE | TICONA LLC (US) | 2015-08-20 | — | — | WO | claimed |
| WO-2015122941-A1 | TOUGHENED POLYARYLENE SULFIDE COMPOSITION | TICONA LLC (US) | 2015-08-20 | — | — | WO | claimed |
| US-20150225567-A1 | Toughened Polyarylene Sulfide Composition | TICONA LLC | 2015-08-13 | — | — | US | claimed |
| US-20150225547-A1 | Molded Part for Use in a Portable Electronic Device | TICONA LLC | 2015-08-13 | — | — | US | claimed |
| US-20140170415-A1 | Multicomponent Fiber Containing a Polyarylene Sulfide | TICONA LLC (US) | 2014-06-19 | — | — | US | claimed |
| US-20130249357-A1 | Housing for a Portable Electronic Device | TICONA LLC (US) | 2013-09-26 | — | — | US | claimed |
| WO-2013052269-A2 | HOUSING FOR A PORTABLE ELECTRONIC DEVICE | TICONA LLC (US) | 2013-04-11 | — | — | WO | claimed |
| US-20030176512-A1 | Asymmetric disulfides and methods of using same | PROLX PHARMACEUTICALS CORPORATION (CA) | 2003-09-18 | — | — | US | claimed |
| US-20260045417-A1 | Film Capacitor Containing A Polyarylene Sulfide | TICONA LLC (US) | 2026-02-12 | — | — | US | disclosed |
| US-20260042903-A1 | Laser Transmissive Polyarylene Sulfide Composition | TICONA LLC (US) | 2026-02-12 | — | — | US | disclosed |
| EP-4662727-A1 | NONAQUEOUS ELECTROCHEMICAL BATTERY CONTAINING A SEALING MEMBER | Ticona LLC (US) | 2025-12-17 | — | — | EP | disclosed |
| EP-4626953-A1 | HYDROLYTICALLY STABLE POLYARYLENE SULFIDE COMPOSITION | Ticona LLC (US) | 2025-10-08 | — | — | EP | disclosed |
| US-20250289956-A1 | Polymer Composition With Improved Thermal Shock Resistance | TICONA LLC | 2025-09-18 | — | — | US | disclosed |
| EP-0136186-B1 | PHOTOCURABLE RESIN COMPOSITION | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1989-09-06 | — | — | EP | disclosed |
| US-4820801-A | HIGH PURITY; FOR ELECTRONIC COATINGS OR ENCAPSULATION | TOSOH CORP. (JP) | 1989-04-11 | — | — | US | disclosed |
| EP-0252603-A2 | Adhesives for ceramics and processes for the bonding of ceramics using same | MITSUI SEKIYU KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1988-01-13 | — | — | EP | disclosed |
| EP-0225471-A1 | Polyphenylene sulfide containing covalently bonded chlorine in a reduced amount and process for producing the same | Tosoh Corporation (JP) | 1987-06-16 | — | — | EP | disclosed |
| US-4548689-A | RADICAL POLYMERIZABLE MONOMER, KETOCARBONYL COMPOUND AND MERCAPTOB | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1985-10-22 | — | — | US | disclosed |
| EP-0136186-A2 | Photocurable resin composition | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1985-04-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042903-A1 | Laser Transmissive Polyarylene Sulfide Composition | TRPC5, TRPC3, TRPC7 | DDAH1 4881/4885ADRA2C 1279/4885ALDH1A1 3998/4885 |
| US-20260045417-A1 | Film Capacitor Containing A Polyarylene Sulfide | SLC39A3, SLC39A11, SLC39A14 | DDAH1 4790/4885ADRA2C 2912/4885ALDH1A1 3715/4885 |
| US-20030176512-A1 | Asymmetric disulfides and methods of using same | PRDX3, PDIA5, PRDX5 | DDAH1 937/4885ADRA2C 4772/4885ALDH1A1 2098/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.